MPhil in Chem & Biomolecular Engg - Synergistic Combination of EGFR-vIII-Targeted CAR-T Cells, Pembrolizumab and Metformin for Overcoming Immunological and Metabolic Resistance in Glioblastoma

Name: MPhil in Chem & Biomolecular Engg - Synergistic Combination of EGFR-vIII-Targeted CAR-T Cells, Pembrolizumab and Metformin for Overcoming Immunological and Metabolic Resistance in Glioblastoma
Start: 2026-08-07
End: 2026-08-07

7 August 2026

4:30pm - 7:30pm

Room 5560 (Lifts 27-28), HKUST

Supporting the below United Nations Sustainable Development Goals:支持以下聯合國可持續發展目標：支持以下联合国可持续发展目标：

Event Format

Thesis Defense

Candidate

WAN, Ching Natalie

Language

English